Exact Mass: 395.15550600000006

Exact Mass Matches: 395.15550600000006

Found 47 metabolites which its exact mass value is equals to given mass value 395.15550600000006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Oxidized Renilla luciferin

N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-phenylacetamide

C25H21N3O2 (395.1633686)

Ketanserin

3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione

C22H22FN3O3 (395.16451140000004)

C - Cardiovascular system > C02 - Antihypertensives > C02K - Other antihypertensives > C02KD - Serotonin antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Ketanserin is a selective 5-HT2 receptor antagonist. Ketanserin also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).

1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinoline

C25H21N3O2 (395.1633686)

Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside

Ethyl 3-(1H-indol-3-yl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

C19H25NO8 (395.158009)

Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is found in alcoholic beverages. Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is isolated from grapes (Reisling wine Isolated from grapes (Reisling wine). Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is found in alcoholic beverages.

Cloricromen

Ethyl 2-({8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-chromen-7-yl}oxy)acetic acid

C20H26ClNO5 (395.1499416000001)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

N-(2,5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide

N-[(2,5-dimethoxyphenyl)methyl]-N-(5-fluoro-2-phenoxyphenyl)acetamide

C23H22FNO4 (395.15327840000003)

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor. Target:PBR in vitro: DAA1106 binding to PBR was significantly increased in widespread areas in MCI subjects when compared to healthy controls.[1] DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. [2] in vivo: DAA-1106 has anxiolytic effects in animal studies. DAA-1106 has a sub-nanomolar binding affinity (Ki) of 0.28nM, and has been used extensively in its 3H or 11C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. [2]

Morniflumate

2-(morpholin-4-yl)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylate

C19H20F3N3O3 (395.1456686)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside

ethyl 3-(1H-indol-3-yl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoate

C19H25NO8 (395.158009)

Z-Trp-Gly-OH

C21H21N3O5 (395.14811360000004)

4-methylbenzenesulfonate,1,2,3,3-tetramethylbenzo[e]indol-3-ium

C23H25NO3S (395.15550600000006)

4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3-morpholinone

C21H21N3O5 (395.14811360000004)

BENZYL 2-ACETAMIDO-2-DEOXY-3,6-DI-O-ACETYL-ALPHA-D-GLUCOPYRANOSIDE

C19H25NO8 (395.158009)

Diethyl [4-(diphenylamino)benzyl]phosphonate

C23H26NO3P (395.1650216000001)

n-benzoyl-dl-phenylalanine 2-naphthyl ester

C26H21NO3 (395.15213560000007)

IRAK-1-4 Inhibitor I

C20H21N5O4 (395.15934660000005)

n-benzoyl-dl-phenylalanine 2-naphthyl ester [for determination of chymotrypsin]

C26H21NO3 (395.15213560000007)

Orbifloxacin

C19H20F3N3O3 (395.1456686)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

AZD2461

C22H22FN3O3 (395.16451140000004)

2-benzyl-1-(2-hydroxyethyl)-3-[(2-methyl-1H-indol-3-yl)azo]-1H-pyrazolium chloride

C21H22ClN5O (395.15127920000003)

N-[(1R)-1-(7,8-Dihydro-1-naphthalenyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propanamine hydrochloride (1:1)

C22H25ClF3N (395.16275160000004)

2-(2-ethylhexyl)-4,7-di-(thiophene-2-yl)-2,1,3-benzotriazole

C22H25N3S2 (395.148981)

Morniflumate

C19H20F3N3O3 (395.1456686)

Cloricromen

Cloricromene

C20H26ClNO5 (395.1499416000001)

Rot-2-enonate

C23H23O6- (395.1494558)

(beta-D-glucosyl)-O-mycofactocinone

C19H25NO8 (395.158009)

1-[2-[[(2-Chloroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C19H26ClN3O4 (395.16117460000004)

5-(2,4-Dimethoxyphenyl)-7-(3,4-dimethoxyphenyl)-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C20H21N5O4 (395.15934660000005)

4-Morpholinecarboxylic acid [3-(6-amino-5-cyano-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl] ester

C20H21N5O4 (395.15934660000005)

1-(1,3-Benzodioxol-5-yl)-3-[4-(4-hydroxyphenyl)piperazin-1-yl]pyrrolidine-2,5-dione

C21H21N3O5 (395.14811360000004)

2-[(4E)-4-[(3-ethoxy-4-hydroxyphenyl)methylidene]-2,5-dioxoimidazolidin-1-yl]-N-(3-methylphenyl)acetamide

C21H21N3O5 (395.14811360000004)

3-Hydroxy-1-adamantanecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] ester

C20H23F2NO5 (395.1544212)

1-[3-(Dimethylamino)propyl]-1-(phenylmethyl)-3-[3-(trifluoromethyl)phenyl]thiourea

C20H24F3N3S (395.16429400000004)

1-[1-(4-Methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone

C21H21N3O5 (395.14811360000004)

2-(Naphthalen-1-ylamino)-N-[(E)-(3-phenoxyphenyl)methylideneamino]acetamide

C25H21N3O2 (395.1633686)

(1S,9R,10R,11R)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid

C21H21N3O5 (395.14811360000004)

(1R,9S,10S,11S)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid

C21H21N3O5 (395.14811360000004)

Ketanserin

C22H22FN3O3 (395.16451140000004)

N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-phenylacetamide

C25H21N3O2 (395.1633686)

Ceranib1

C26H21NO3 (395.15213560000007)

Ceranib1 is a ceramidase inhibitor. Ceranib1 inhibits ceramidase activity toward an exogenous ceramide analog, induces the accumulation of multiple ceramide species, decreases levels of sphingosine and S1P. Ceranib1 inhibits the proliferation of ovarian cancer cells[1].

(4as,6s,7r,7as)-1-hydroxy-4-(methoxycarbonyl)-7-methyl-4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

C21H21N3O5 (395.14811360000004)

3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-phenyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H21NO3 (395.15213560000007)

3-hydroxy-6-[2-(5-hydroxy-5-methylhexyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

C18H25N3O5S (395.15148400000004)

1-hydroxy-4-(methoxycarbonyl)-7-methyl-4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

C21H21N3O5 (395.14811360000004)